SAL0140

DRUG2 trials

Sponsors

Shenzhen Salubris Pharmaceuticals Co., Ltd.

Conditions

Uncontrolled Hypertension

Phase 1

SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population

RecruitingNCT07051603

Shenzhen Salubris Pharmaceuticals Co., Ltd.Uncontrolled Hypertension

Start: 2025-06-09End: 2026-02-28Target: 82Updated: 2025-07-04

Phase 2

A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension

RecruitingNCT07654140

Shenzhen Salubris Pharmaceuticals Co., Ltd.Uncontrolled Hypertension

Start: 2025-12-09End: 2027-07-31Target: 252Updated: 2026-06-17